NeuroPace’s third-quarter revenue fell 1% year over year to $23.1 million, below the $27.16 million analyst estimate. The company cut its 2026 revenue outlook to $91 million-$92 million from $99.5 million-$101.5 million while raising its gross margin outlook and lowering its operating expense forecast.
NeuroPace reported third-quarter revenue of $23.1 million, down 1% year over year and below the $27.16 million analyst estimate. Net loss narrowed to $3.3 million, and loss per share was $0.10.
The company lowered its 2026 revenue guidance to $91 million-$92 million from $99.5 million-$101.5 million. It raised its non-GAAP gross margin outlook to 83.0%-83.5% from 82.0%-83.0% and lowered its non-GAAP operating expense forecast to $85 million-$86 million from $90 million-$92 million.
NeuroPace said the revenue shortfall was concentrated in several large accounts and reflected isolated account-level issues and field organization changes. It said it is taking action to improve commercial execution and return to historical growth rates.
